Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kate Farnsworth
Observed name:
Farnsworth, Kate
Observed institution:
Diabetes Action Canada
ORCID:
0000-0003-4272-8131
Observed ORCID:
0000-0003-4272-8131
OpenAlex ID:
A5073189130
Assessment of Risks and Benefits of Beta Cell Replacement Versus Automated Insulin Delivery Systems for Type 1 Diabetes
2020
·
Peter Senior
, Anna Lam
, et al.
·
Current Diabetes Reports
·
17
Do-It-Yourself Automated Insulin Delivery: A Position Statement
2023
·
Ilana J. Halperin
, Alanna Chambers
, et al.
·
Canadian Journal of Diabetes
·
8
Do-It-Yourself Automated Insulin Delivery: A Health-care Practitioner User’s Guide
2023
·
Alanna Chambers
, Dylan Mackay
, et al.
·
Canadian Journal of Diabetes
·
5
Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers
2022
·
Amy E. Morrison
, Peter A. Senior
, et al.
·
Canadian Journal of Diabetes
·
5
PDF
Improved Glycemia and Quality of Life Among Loop Users: Analysis of Real-world Data From a Single Center
2022
·
Amy E Morrison
, Kimberley Chong
, et al.
·
JMIR Diabetes
·
4
PDF
Improved Glycemia and Quality of Life Among Loop users – Analysis of Real-World Data from a Single Centre (Preprint)
2022
·
Amy E. Morrison
, Kimberley Chong
, et al.
Connect1d Canada Validation Study in Patient-Driven Design to Accelerate Research in Type 1 Diabetes
2021
·
Peter Senior
, Kate Farnsworth
, et al.
·
Canadian Journal of Diabetes
Show more works
View as search
Works count:
9
Citation count:
39
H-index:
4
I10-index:
1
Year
Topic
Type
